Lack of News4 Mar 2021 10:59
I sent the below to N4P's broker and PR company. Obviously, they couldn't say much so was wondering about other peoples thoughts
I just want to ask a few questions.
Like you can ‘only make announcements when we are in receipt of the relevant information, we can only make a judgement by what information we are given. In the RNS dated the 11th Feb Nigel was quoted as saying
“We look forward to providing a full update on all our workstreams, including our oral and oncology work, when we publish our full-year results for the year ended 31 December 2020 which is expected to be towards the end of February / early March."
So, the year-end results have been published so why no ‘full update’ as well?
I feel today’s RNS reads rather dourly, even though you might add it is just the full-year results. Not many positive words like previous RNS’s which, reading between the lines, does not bode well. As agreed by other investors.
in a previous RNS on Nov 5th Nigel said of the Oral testing ‘The Company expects to have some data following the results of planned studies as to its viability towards the end of this year’ Todays RNS has him saying ‘This work on oral delivery will continue in the background as there is much that needs doing to establish the potential for Nuvec® in this area as no one experiment will provide a definitive conclusion either way on this potential.’ So again are we led to believe that the results, we are not known publicly, have not been positive?
Finally, it does mention the Intention to grant a patent in Australia, which is great news, why was it felt that was not worthy of a RNS? You saw how positively the share price reacted when the news of the previous grant to Patent was announced.
Nigel mentioned how pivotal the next 6 months are for the company last year and we are well into that period but the share price is 30% below its recent highs. This makes me wondered why investors are not excited about the N4P??